Magnesium and cardiovascular complications of chronic kidney disease. Massy, Ziad A.; Drüeke, Tilman B.. Nature Reviews. Nephrology. 2015; 432-442: p.432-442. doi:10.1038/nrneph.2015.74Article
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Blanchard, P.; Lee, A.; Marguet, S.; Leclercq, J.; Ng, W. T.; Ma, J.; Chan, A. T.; Huang, P. Y.; Benhamou, E.; Zhu, G.; Chua, D. T.; Chen, Y.; Mai, H. Q.; Kwong, D. L.; Cheah, S. L.; Moon, J.; Tung, Y.; Chi, K. H.; Fountzilas, G.; Zhang, L.; Hui, E. P.; Lu, T. X.; Bourhis, J.; Pignon, J. P.; Group, Mac-Npc Collaborative. Lancet Oncol. 2015; 645-55: p.645-55. doi:10.1016/S1470-2045(15)70126-9 10.1016/S1470-2045(15)70126-9. Epub 2015 May 6.Article
Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling. de Seigneux, Sophie; Courbebaisse, Marie; Rutkowski, Joseph M.; Wilhelm-Bals, Alexandra; Metzger, Marie; Khodo, Stellor Nlandu; Hasler, Udo; Chehade, Hassib; Dizin, Eva; Daryadel, Arezoo; Stengel, Bénedicte; NephroTest Study Group; Girardin, E.; Prié, Dominique; Wagner, Carsten A.; Scherer, Philipp E.; Martin, Pierre-Yves; Houillier, Pascal; Feraille, Eric. Journal of the American Society of Nephrology: JASN. 2015; 1608-1618: p.1608-1618. doi:10.1681/ASN.2014010104Article
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up. Lepoutre-Lussey, C.; Caramella, C.; Bidault, F.; Déandreis, D.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Borget, I.; Gimenez-Roqueplo, A. P.; Dumont, F.; Deschamps, F.; Nascimento, C.; Lumbroso, J.; Guillaud Bataille, M.; Schlumberger, M.; Baudin, E.; Leboulleux, S.. Eur. J. Nucl. Med. Mol. Imaging. 2015; 868-76: p.868-76Article
Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort. Azevedo Da Silva, Marine; Dugravot, Aline; Balkau, Beverley; Roussel, Ronan; Fumeron, Frédéric; Elbaz, Alexis; Canonico, Marianne; Singh-Manoux, Archana; Nabi, Hermann; D.E.S.I.R. Study Group. International Journal of Epidemiology. 2015; : . doi:10.1093/ije/dyv153Article
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement. Stewart, L. A.; Clarke, M.; Rovers, M.; Riley, R. D.; Simmonds, M.; Stewart, G.; Tierney, J. F.; Group, Prisma-Ipd Development. JAMA. 2015; 1657-65: p.1657-65. doi:10.1001/jama.2015.3656 10.1001/jama.2015.3656.Article
Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physicians. Billaux, M.; Borget, I.; Prognon, P.; Pineau, J.; Martelli, N.. Aust Health Rev. 2015; 257-61: p.257-61. doi:10.1071/AH15039 10.1071/AH15039.Article
Precision medicine: lessons learned from the SHIVA trial - Authors' reply. Le Tourneau, C.; Belin, L.; Paoletti, X.; Bieche, I.; Kamal, M.. Lancet Oncol. 2015; e581-2: p.e581-2. doi:10.1016/S1470-2045(15)00455-6 10.1016/S1470-2045(15)00455-6.Article
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial. Salgado, R.; Denkert, C.; Campbell, C.; Savas, P.; Nuciforo, P.; Aura, C.; de Azambuja, E.; Eidtmann, H.; Ellis, C. E.; Baselga, J.; Piccart-Gebhart, M. J.; Michiels, S.; Bradbury, I.; Sotiriou, C.; Loi, S.. JAMA Oncol. 2015; 448-54: p.448-54. doi:10.1001/jamaoncol.2015.0830 10.1001/jamaoncol.2015.0830.Article
Continence Across Continents To Upend Stigma and Dependency (CACTUS-D): study protocol for a cluster randomized controlled trial. Tannenbaum, C.; van den Heuvel, E.; Fritel, X.; Southall, K.; Jutai, J.; Rajabali, S.; Wagg, A.. Trials. 2015; 565: p.565. doi:10.1186/s13063-015-1099-x 10.1186/s13063-015-1099-x [pii]Article
Oncostat